BrainCore Therapy offers a drugless approach to treating Brainwave Dysregulation associated with various neurological based conditions including ADHD, Insomnia, Anxiety, Panic Attacks, PTSD, Autism, Traumatic Brain Injury, Migraines, and Learning Disorders. With over 125 practices in the U.S. and Canada using BrainCore Therapy's neurofeedback protocols and technologies, the company operates in the Care Economy and Health Care industries. Although the founding date and headquarters are not specified, the potential for investment in this innovative therapy, given its broad application and proliferation, could pique the interest of venture capital firms. A deep dive into their operations and technological advancements would be essential for potential investors seeking to tap into this burgeoning field.
There is no investment information
No recent news or press coverage available for BrainCore Therapy.